ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
MH
Metropolitan Hospital at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Metropolitan Hospital takes part in 5 sessions at ESMO 2026 in Madrid. Its sessions focus on cancer detection and outcomes, especially in breast and pancreatic cancer. They examine liquid-biopsy detection of RAS mutations in pancreatic cancer and differences between breast cancer needle biopsies and surgical samples.
| Organization | ESMO 2026 Attendance |
|---|---|
MH Metropolitan Hospital Athens, Greece | |
Private hospital in Athens, Greece. | Poster Fri Oct 23 13:00–15:00 RAS mutation detection by liquid biopsy in unresectable pancreatic cancer: Correlation with biomarkers, clinical parameters, and tumor molecular features - a prospective observational study Gastrointestinal cancersBiomarkers & precision oncology Poster Fri Oct 23 13:00–15:00 Poster Fri Oct 23 15:15–16:00 Poster Sat Oct 24 12:00–12:45 NOLUS as a surrogate marker of genomic risk in HR+/HER2- early breast cancer Breast cancerBiomarkers & precision oncology Talk Sun Oct 25 08:30–08:50 Chair Sun Oct 25 08:30–10:00 Talk Sun Oct 25 09:10–09:50 Talk Sun Oct 25 09:50–10:00 |
Find decision makers at Metropolitan Hospital
Tell us what you sell and we’ll find the people at Metropolitan Hospital most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction